Sabela Ojea

Key Takeaways: Family divisions at Estée Lauder and Puig are at the heart of the acquisitions talks, underway since the second half of 2025.

Key Takeaways: Bloomingdale's is outperforming rivals by balancing premium and luxury brands while investing in curated experiences.

Step into the machine at Neko Health or one of its rivals to check for skin cancer, diabetes or stroke risk. Is this the next frontier in preventative health care, or something your primary care physician would rather you avoid?

Key Takeaways: Estée Lauder's recovery narrative has unraveled since confirming talks with Puig, wiping out roughly $15 billion in market value.

Key Takeaways: Advent taps Jefferies and Goldman Sachs to run a potential sale of Parfums de Marly, with the process still at early stage.

Key Takeaways: Henkel has acquired Olaplex at a steep discount, but innovation focus could risk repeating the same mistakes made under Advent International ownership.

Key Takeaways: Puig CEO Marc Puig told investors Puig was “frustrated” with its share performance following its May 2024 IPO.

“The Middle East is a region where we are reasonably exposed, and we're observing a true slowdown, but it's not collapsing,” Simon said, referring

Biologique Recherche, the French professional skincare brand known for its clinical, spa-led model, is exploring a potential sale, according to sources familiar with the matter.

Key Takeaways: Estée Lauder spent $100 million pursuing a deal Puig viewed as a lowball takeover attempt.